Therefore, it is plausible to envisage that tumor cell release of CD63 and TIMP-1 via exosomes might result in the horizontal transfer of malignant traits to recipient cells, thereby promoting tumor progression and resistance to therapy. Here, CD63 is linked to neoplasm.